The Regulatory System May Not Be Ready for Synthetic Organisms
By Susana Medeiros,
RegBlog
| 07. 15. 2015
Untitled Document
Scientists are working on synthetically designed microorganisms that may soon produce everything from the fuel in your gas tank to your Spandex. Distinct from genetically modified organisms, which are created by the transfer of small amounts of genetic material, synthetic biology allows scientists to assemble entirely new organisms that may be more efficient than those naturally occurring in nature.
Some of these organisms can even function as tiny factories to produce rare and expensive chemicals and compounds. For example, Exxon expects to spend over $600 million towards the development of synthetic algae that may serve as an alternative biofuel over the next decade. Synthetic organisms could even be designed specifically to be released into the environment and consume carbon dioxide, mollifying the effects of global warming.
However, despite its potential advantages, synthetic biology could also produce dangers that are not met by the nation’s current regulatory system, according to a recent article by law professors Gregory N. Mandel and Gary E. Marchant.
Synthetic biology is currently regulated based on its use, typically by the U.S. Environmental Protection...
Related Articles
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
After almost 20 years of publicity stunts and dubious claims, we may not have 23andMe to kick around anymore. The company has filed for Chapter 11 bankruptcy protection. The stock has collapsed to about 2% of its peak value. CEO and co-founder Anne Wojcicki has quit (though she may be baaack) and the company’s future, if any, depends on its DNA database.
Note to customers of the company: Get Out. Cybersecurity expert Adrianus Warmenhoven told the Associated Press...
By ACLU Northern California
| 03.21.2025
In a long-standing lawsuit, the ACLU, on behalf of partner organizations and an individual taxpayer, is challenging the state of California for its retention of genetic samples and profiles from people arrested but never convicted of a felony.
The complaint...
By Loren Johnston, Portland Press Herald | 03.15.2025